首页> 外文期刊>Human Genetics >Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
【24h】

Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).

机译:遗传性肾细胞癌新家族和易位t(3; 8)(p13; q24.1)的分子研究。

获取原文
获取原文并翻译 | 示例
           

摘要

An alternative model has been proposed for the development of clear-cell renal cell carcinoma (RCC) in families where chromosome 3 translocations segregate with the disease. In this model, the existence of a translocation involving chromosome 3 would favour the non-disjunctional loss of the derivative chromosome carrying the 3p segment. Additionally, subsequent somatic mutations in the VLH gene, located in 3p25-26, would inactivate this tumour suppressor gene. In the present work, we describe a new family with two clear-cell RCC affected members and a t(3;8)(p13;q24.1) translocation in two consecutive generations. We observed loss of the derivative chromosome carrying the 3p segment (der(8)) and somatic mutation of the VHL gene in the left-kidney tumoral tissue of the proband. His right-kidney tumour carried a different VHL mutation and loss of heterozygosity (LOH) was not detected. The mother of the proband was also clear-cell RCC-affected but the tumoral tissue analysed did not carry any VHL gene mutations. Another member of the family, a maternal aunt, had a papillary RCC and did not carry this translocation, the LOH on 3p or the VHL somatic mutations. Haplotype analysis of the three affected members revealed that they did not inherit a common region on 3p, confirming the different genetic origin of both tumour types. Finally, the presence of RCC in other non-available members of the family highlights the overall risk for RCC in families with chromosome 3 translocations. In the present work, we have confirmed the proposed mechanism for the development of clear-cell RCC in this family, although we cannot discard the existence of other genes, in addition to VHL, being involved in hereditary RCC.
机译:已经提出了一种替代模型,用于在染色体3易位与该疾病隔离的家庭中发展透明细胞肾细胞癌(RCC)。在此模型中,涉及3号染色体的易位的存在将有利于携带3p片段的衍生染色体的非分离损失。此外,位于3p25-26的VLH基因的后续体细胞突变将使该抑癌基因失活。在当前的工作中,我们描述了一个新家族,该家族有两个受到透明细胞RCC影响的成员,并且连续两个世代都有t(3; 8)(p13; q24.1)易位。我们观察到先证者左肾肿瘤组织中携带3p区段(der(8))的衍生染色体丢失和VHL基因的体细胞突变。他的右肾肿瘤带有不同的VHL突变,未检测到杂合性(LOH)丢失。先证者的母亲也受到透明细胞RCC的影响,但是分析的肿瘤组织没有携带任何VHL基因突变。该家庭的另一个成员,一个母亲姑姑,患有乳头状RCC,并且没有携带这种易位,3p的LOH或VHL的体细胞突变。对三个受影响成员的单倍型分析显示,他们没有在3p上遗传一个共同区域,从而证实了两种肿瘤类型的不同遗传起源。最后,RCC在其他无法获得的家庭成员中的存在凸显了3号染色体易位家庭中RCC的总体风险。在目前的工作中,我们已经证实了该家族中透明细胞RCC发育的拟议机制,尽管我们不能抛弃除VHL之外还参与遗传性RCC的其他基因的存在。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号